784 related articles for article (PubMed ID: 18780809)
1. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal.
Darrouj J; Puri N; Prince E; Lomonaco A; Spevetz A; Gerber DR
Ann Pharmacother; 2008 Nov; 42(11):1703-5. PubMed ID: 18780809
[TBL] [Abstract][Full Text] [Related]
2. Review of adjunctive dexmedetomidine in the management of severe acute alcohol withdrawal syndrome.
Wong A; Smithburger PL; Kane-Gill SL
Am J Drug Alcohol Abuse; 2015; 41(5):382-91. PubMed ID: 26337198
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters.
MacLaren R; Forrest LK; Kiser TH
Pharmacotherapy; 2007 Mar; 27(3):351-9. PubMed ID: 17316147
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report.
Rovasalo A; Tohmo H; Aantaa R; Kettunen E; Palojoki R
Gen Hosp Psychiatry; 2006; 28(4):362-3. PubMed ID: 16814639
[TBL] [Abstract][Full Text] [Related]
5. Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate.
O'Mara K; Gal P; Ransommd JL; Wimmermd JE; Carlosmd RQ; Dimaguilamd MA; Davonzomd C; Smithmd M
Ann Pharmacother; 2009 Oct; 43(10):1707-13. PubMed ID: 19755621
[TBL] [Abstract][Full Text] [Related]
6. Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome.
Hayner CE; Wuestefeld NL; Bolton PJ
Pharmacotherapy; 2009 Jul; 29(7):875-8. PubMed ID: 19558262
[TBL] [Abstract][Full Text] [Related]
7. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
Ferenchak TA
J Addict Nurs; 2017; 28(4):E1-E2. PubMed ID: 29200055
[TBL] [Abstract][Full Text] [Related]
8. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
Ferenchak TA
J Addict Nurs; 2017; 28(4):188-195. PubMed ID: 29200045
[TBL] [Abstract][Full Text] [Related]
9. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it.
Prescrire Int; 2007 Feb; 16(87):24-31. PubMed ID: 17323538
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit.
Arpino PA; Kalafatas K; Thompson BT
J Clin Pharm Ther; 2008 Feb; 33(1):25-30. PubMed ID: 18211613
[TBL] [Abstract][Full Text] [Related]
11. Use of dexmedetomidine in the pediatric intensive care unit.
Buck ML; Willson DF
Pharmacotherapy; 2008 Jan; 28(1):51-7. PubMed ID: 18154474
[TBL] [Abstract][Full Text] [Related]
12. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.
DeCarolis DD; Rice KL; Ho L; Willenbring ML; Cassaro S
Pharmacotherapy; 2007 Apr; 27(4):510-8. PubMed ID: 17381377
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium.
Tolonen J; Rossinen J; Alho H; Harjola VP
Eur J Emerg Med; 2013 Dec; 20(6):425-7. PubMed ID: 23247391
[TBL] [Abstract][Full Text] [Related]
15. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
Woods AD; Giometti R; Weeks SM
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
[TBL] [Abstract][Full Text] [Related]
16. Use of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation: a pilot study.
Siobal MS; Kallet RH; Kivett VA; Tang JF
Respir Care; 2006 May; 51(5):492-6. PubMed ID: 16638158
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature.
Gerlach AT; Murphy CV
Pharmacotherapy; 2009 Dec; 29(12):1492. PubMed ID: 19947809
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review protocol.
Fiore M; Torretta G; Passavanti MB; Sansone P; Pace MC; Alfieri A; Aurilio C; Simeon V; Chiodini P; Pota V
JBI Database System Rev Implement Rep; 2019 Oct; 17(10):2159-2164. PubMed ID: 31232889
[TBL] [Abstract][Full Text] [Related]
19. Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis.
Dasta JF; Jacobi J; Sesti AM; McLaughlin TP
Pharmacotherapy; 2006 Jun; 26(6):798-805. PubMed ID: 16716133
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury.
Tang JF; Chen PL; Tang EJ; May TA; Stiver SI
Neurocrit Care; 2011 Aug; 15(1):175-81. PubMed ID: 20198514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
